CAPRICOR THERAPEUTICS, INC. - 10-Q Filing
Capricor Therapeutics reports Q3 2026 financial results and updates on licensing agreements and equity programs.
Tickers: $CAPR
Capricor Therapeutics reports Q3 2026 financial results and updates on licensing agreements and equity programs.
Tickers: $CAPR